321 related articles for article (PubMed ID: 25772236)
1. PML isoforms IV and V contribute to adenovirus-mediated oncogenic transformation by functionally inhibiting the tumor-suppressor p53.
Wimmer P; Berscheminski J; Blanchette P; Groitl P; Branton PE; Hay RT; Dobner T; Schreiner S
Oncogene; 2016 Jan; 35(1):69-82. PubMed ID: 25772236
[TBL] [Abstract][Full Text] [Related]
2. SUMO modification of E1B-55K oncoprotein regulates isoform-specific binding to the tumour suppressor protein PML.
Wimmer P; Schreiner S; Everett RD; Sirma H; Groitl P; Dobner T
Oncogene; 2010 Oct; 29(40):5511-22. PubMed ID: 20639899
[TBL] [Abstract][Full Text] [Related]
3. Adenovirus E1B 55-kilodalton protein is a p53-SUMO1 E3 ligase that represses p53 and stimulates its nuclear export through interactions with promyelocytic leukemia nuclear bodies.
Pennella MA; Liu Y; Woo JL; Kim CA; Berk AJ
J Virol; 2010 Dec; 84(23):12210-25. PubMed ID: 20861261
[TBL] [Abstract][Full Text] [Related]
4. Adenovirus type 5 early region 1B 55K oncoprotein-dependent degradation of cellular factor Daxx is required for efficient transformation of primary rodent cells.
Schreiner S; Wimmer P; Groitl P; Chen SY; Blanchette P; Branton PE; Dobner T
J Virol; 2011 Sep; 85(17):8752-65. PubMed ID: 21697482
[TBL] [Abstract][Full Text] [Related]
5. E1B-55K-Mediated Regulation of RNF4 SUMO-Targeted Ubiquitin Ligase Promotes Human Adenovirus Gene Expression.
Müncheberg S; Hay RT; Ip WH; Meyer T; Weiß C; Brenke J; Masser S; Hadian K; Dobner T; Schreiner S
J Virol; 2018 Jul; 92(13):. PubMed ID: 29695423
[TBL] [Abstract][Full Text] [Related]
6. Sp100A is a tumor suppressor that activates p53-dependent transcription and counteracts E1A/E1B-55K-mediated transformation.
Berscheminski J; Brun J; Speiseder T; Wimmer P; Ip WH; Terzic M; Dobner T; Schreiner S
Oncogene; 2016 Jun; 35(24):3178-89. PubMed ID: 26477309
[TBL] [Abstract][Full Text] [Related]
7. Adenovirus E1B 55-kilodalton oncoprotein binds to Daxx and eliminates enhancement of p53-dependent transcription by Daxx.
Zhao LY; Colosimo AL; Liu Y; Wan Y; Liao D
J Virol; 2003 Nov; 77(21):11809-21. PubMed ID: 14557665
[TBL] [Abstract][Full Text] [Related]
8. The adenovirus E1B-55K oncoprotein induces SUMO modification of p53.
Muller S; Dobner T
Cell Cycle; 2008 Mar; 7(6):754-8. PubMed ID: 18461721
[TBL] [Abstract][Full Text] [Related]
9. Adenovirus type 5 early region 1B 156R protein promotes cell transformation independently of repression of p53-stimulated transcription.
Sieber T; Dobner T
J Virol; 2007 Jan; 81(1):95-105. PubMed ID: 17050591
[TBL] [Abstract][Full Text] [Related]
10. The human adenovirus E1B-55K oncoprotein coordinates cell transformation through regulation of DNA-bound host transcription factors.
von Stromberg K; Seddar L; Ip WH; Günther T; Gornott B; Weinert SC; Hüppner M; Bertzbach LD; Dobner T
Proc Natl Acad Sci U S A; 2023 Oct; 120(44):e2310770120. PubMed ID: 37883435
[TBL] [Abstract][Full Text] [Related]
11. Proteasome-dependent degradation of Daxx by the viral E1B-55K protein in human adenovirus-infected cells.
Schreiner S; Wimmer P; Sirma H; Everett RD; Blanchette P; Groitl P; Dobner T
J Virol; 2010 Jul; 84(14):7029-38. PubMed ID: 20484509
[TBL] [Abstract][Full Text] [Related]
12. Blockage of CRM1-dependent nuclear export of the adenovirus type 5 early region 1B 55-kDa protein augments oncogenic transformation of primary rat cells.
Endter C; Härtl B; Spruss T; Hauber J; Dobner T
Oncogene; 2005 Jan; 24(1):55-64. PubMed ID: 15480414
[TBL] [Abstract][Full Text] [Related]
13. E1B 55K sequesters WT1 along with p53 within a cytoplasmic body in adenovirus-transformed kidney cells.
Maheswaran S; Englert C; Lee SB; Ezzel RM; Settleman J; Haber DA
Oncogene; 1998 Apr; 16(16):2041-50. PubMed ID: 9572485
[TBL] [Abstract][Full Text] [Related]
14. Conserved E1B-55K SUMOylation in Different Human Adenovirus Species Is a Potent Regulator of Intracellular Localization.
Kolbe V; Ip WH; Kieweg-Thompson L; Lang J; Gruhne J; Meyer T; Wilkens B; Schie M; Thünauer R; Schreiner S; Bertzbach LD; Rodríguez E; Dobner T
J Virol; 2022 Feb; 96(3):e0083821. PubMed ID: 34787461
[TBL] [Abstract][Full Text] [Related]
15. β-catenin inhibits promyelocytic leukemia protein tumor suppressor function in colorectal cancer cells.
Satow R; Shitashige M; Jigami T; Fukami K; Honda K; Kitabayashi I; Yamada T
Gastroenterology; 2012 Mar; 142(3):572-81. PubMed ID: 22155184
[TBL] [Abstract][Full Text] [Related]
16. Role of SUMO in RNF4-mediated promyelocytic leukemia protein (PML) degradation: sumoylation of PML and phospho-switch control of its SUMO binding domain dissected in living cells.
Percherancier Y; Germain-Desprez D; Galisson F; Mascle XH; Dianoux L; Estephan P; Chelbi-Alix MK; Aubry M
J Biol Chem; 2009 Jun; 284(24):16595-16608. PubMed ID: 19380586
[TBL] [Abstract][Full Text] [Related]
17. Wild-type p53 mediates apoptosis by E1A, which is inhibited by E1B.
Debbas M; White E
Genes Dev; 1993 Apr; 7(4):546-54. PubMed ID: 8384580
[TBL] [Abstract][Full Text] [Related]
18. Adenovirus type 5 early region 1B 55-kDa oncoprotein can promote cell transformation by a mechanism independent from blocking p53-activated transcription.
Härtl B; Zeller T; Blanchette P; Kremmer E; Dobner T
Oncogene; 2008 Jun; 27(26):3673-84. PubMed ID: 18212738
[TBL] [Abstract][Full Text] [Related]
19. PML IV/ARF interaction enhances p53 SUMO-1 conjugation, activation, and senescence.
Ivanschitz L; Takahashi Y; Jollivet F; Ayrault O; Le Bras M; de Thé H
Proc Natl Acad Sci U S A; 2015 Nov; 112(46):14278-83. PubMed ID: 26578773
[TBL] [Abstract][Full Text] [Related]
20. A cytoplasmic PML mutant inhibits p53 function.
Bellodi C; Kindle K; Bernassola F; Cossarizza A; Dinsdale D; Melino G; Heery D; Salomoni P
Cell Cycle; 2006 Nov; 5(22):2688-92. PubMed ID: 17172828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
